By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Padualaan 8 (postvak 133)

  Utrecht  3584 CH  The Netherlands
Phone: 31-0-30-253-8800 Fax:


Company News
Merus (MRUS) Expands Executive Management Team With The Appointment Of L. Andres Sirulnik, MD, Phd, As Chief Medical Officer 10/26/2016 7:56:50 AM
Merus (MRUS) Receives Milestone Payment From Ono Pharma (OPHLY) For Selection Of Bispecific Antibody Candidate For Clinical Development And Extends Partnership With CMC Service Agreement 10/19/2016 7:49:51 AM
Merus (MRUS) Announces Reduced Interest Rate On Senior Secured Debt And Reduced Leverage 10/3/2016 9:50:58 AM
Merus (MRUS) To Participate In Upcoming Investor Conferences 8/31/2016 7:53:38 AM
Merus (MRUS) To Present At The 2016 Wedbush PacGrow Healthcare Conference 8/10/2016 10:52:23 AM
Merus (MRUS) Announces Second Quarter 2016 Financial Results And Reviews Recent Clinical Progress And Corporate Developments 8/8/2016 8:10:37 AM
Merus (MRUS) Announces Reduced Leverage And Provides Business Update 7/5/2016 6:53:26 AM
Former Execs at Acerus (TRLPF) and Takeda (TKPYY) Land New Gigs at Merus (MRUS) 7/1/2016 6:33:43 AM
Merus (MRUS) Signs Commercial Multi-Product License For ProBioGen AG’s Glymaxx ADCC Enhancement Technology 6/1/2016 8:09:45 AM
Merus (MRUS) Announces Closing Of Partial Exercise Of Underwriters' Over-Allotment Option 5/31/2016 8:16:53 AM